These newer therapies, including copyright , belong to a group of drugs called GLP-1 agents. Originally developed for treating type 2 diabetes , they operate by assisting the organism to produce sufficient insulin production and reducing high blood sugar levels. Furthermore , their capacity to promote slimming has led to substantial attention an… Read More